Scherak O, Linkesch W
Z Rheumatol. 1983 May-Jun;42(3):130-2.
20 patients with rheumatoid arthritis were treated with oral iron for 6 months and hematological parameters including serum ferritin levels and iron absorption were studied. 13 patients (group 1) had iron deficiency as estimated by low serum ferritin concentration (less than or equal to 30 micrograms/l); the other 7 patients (group 2) revealed normal ferritin levels. After treatment with oral iron, patients of group 1 show a significant increase in serum ferritin, serum iron, hematocrit, erythrocytes, and hemoglobin, a significant decrease in transferrin, and diminished iron absorption. In contrast, in group 2 there was no change in the above-mentioned parameters. The evaluation of iron stores by serum ferritin levels is limited to patients with inactive rheumatoid arthritis. Patients with active disease show hyperferritinemia which no longer represents the iron stores. In this case patients with active rheumatoid arthritis and iron deficiency could reveal normal serum ferritin values.
20例类风湿性关节炎患者接受口服铁剂治疗6个月,并对包括血清铁蛋白水平和铁吸收在内的血液学参数进行了研究。根据低血清铁蛋白浓度(小于或等于30微克/升)估计,13例患者(第1组)存在缺铁;其他7例患者(第2组)铁蛋白水平正常。口服铁剂治疗后,第1组患者的血清铁蛋白、血清铁、血细胞比容、红细胞和血红蛋白显著增加,转铁蛋白显著降低,铁吸收减少。相比之下,第2组上述参数没有变化。通过血清铁蛋白水平评估铁储存仅限于非活动性类风湿性关节炎患者。活动性疾病患者表现为高铁蛋白血症,这不再代表铁储存情况。在这种情况下,活动性类风湿性关节炎和缺铁患者的血清铁蛋白值可能正常。